Investor Alert

July 19, 2021, 8:18 a.m. EDT

CDC vaccine committee to discuss COVID-19 booster doses for immunocompromised people this week

The Centers for Disease Control and Prevention's influential vaccine advisory committee plans to meet Thursday to discuss the new safety warning for Johnson & Johnson's (NYS:JNJ) COVID-19 vaccine and whether immunocompromised people will need a booster dose of a COVID-19 shot. The CDC's Advisory Committee on Immunization Practices has met several times during the pandemic to discuss COVID-19 vaccines. The meeting will be webcast.

Link to MarketWatch's Slice.